Catalyst Wire Dossier Catalyst Wire Dossier

Idiotype vaccine (tumor-derived immunoglobulin idiotype antigen vaccine)

tumor-derived immunoglobulin idiotype vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Idiotype vaccine (tumor-derived immunoglobulin idiotype antigen vaccine), covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines [Phase 1]

See pricing